Biocon shares rose after USFDA issues 'no observations' on Bengaluru facility
Zee Business Video Team | Updated: June 5, 2023 03:43 PM IST
Biocon shares on June 5 edged higher on the back of the USFDA issuing 'no observations' on the company's oral solid dosage formulations manufacturing facility at Bengaluru.